Last reviewed · How we verify

NCT04718688

Exploring the Use of the CO-OP With Children With EF Functions Deficits Following ABI

Completed NA Last updated 22 January 2021
What this trial tests

NA trial testing CO-OP rehabilitation in Acquired Brain Injury in 2 participants. Completed in 30 June 2018.

Timeline
1 January 2018
Primary endpoint
30 June 2018
30 June 2018

Quick facts

Lead sponsorHopitaux de Saint-Maurice
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment2
Start date1 January 2018
Primary completion30 June 2018
Estimated completion30 June 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hopitaux de Saint-Maurice

Who can join

Adults 8 to 14, any sex, with Acquired Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: Acquired brain injury (ABI) in childhood are the cause of disabling motor, cognitive and behavioural disorders, with severe consequences on the later development of autonomy and learning, with long-term repercussions on independence for activities of daily living, and social and professional integration. Among cognitive disorders, executive function (EF) deficits are among the most frequent and disabling, with major consequences on the development of autonomy and the course of schooling and learning. The Cognitive Orientation to daily Occupational Performance (CO-OP) could be an interesting approach for the rehabilitation of these consequences. CO-OP is a performance-based treatment approach for children and adults who experience difficulties performing the skills they want to, need to or are expected to perform. CO-OP is a specifically tailored, active client-centered approach that engages the individual at the meta-cognitive level to solve performance problems. Focused on enabling success, the CO-OP approach employs collaborative goal setting, dynamic performance analysis, cognitive strategy use, guided discovery, and enabling principles. It has been shown to be effective in a variety of populations, but has been little explored in children with ABI. Objectives To assess whether the use of CO-OP could be of interest in children with executive functions deficits following ABI, to improve their occupational performance, their executive functioning in everyday life and their cognitive processes constituting EF.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exploring the use of the Cognitive Orientation to daily Occupational Performance approach (CO-OP) with children with executive functions deficits after severe acquired brain injury: A single case experimental design study.
    Lebrault H, Chavanne C, Abada G, Latinovic B, et al · · 2021 · cited 10× · PMID 33933689 · DOI 10.1016/j.rehab.2021.101535

Verify or expand the search:

Other recruiting trials for Acquired Brain Injury

Currently open trials in the same condition.

Other Hopitaux de Saint-Maurice trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04718688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing